Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
28.00
-1.05 (-3.61%)
At close: Sep 25, 2026, 4:00 PM EDT
27.91
-0.09 (-0.32%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $723.53 million as of September 25, 2026. Its market cap has increased by 6,259.69% in one year.
Market Cap
723.53M
Enterprise Value
537.68M
1-Year Change
6,259.69%
Ranking
Category
Stock Price
$28.00
ChartMarket Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has increased from $558.65M to $723.53M, an increase of 29.51%. That is a compound annual growth rate of 4.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 723.53M | 5,276.24% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 872.31M |
| Ardelyx | 868.42M |
| Solid Biosciences | 863.16M |
| Attovia Therapeutics | 853.68M |
| 4D Molecular Therapeutics | 851.31M |
| Immix Biopharma | 847.03M |
| Avalo Therapeutics | 832.07M |
| Inventiva | 828.70M |